From Zacks Investment Research: 2025-04-10 19:00:00

Zacks Research Daily presents new research reports on 16 major stocks, including Eli Lilly, American Express, and Thermo Fisher Scientific. Eli Lilly’s shares have outperformed the Large Cap Pharmaceuticals industry due to new drug approvals, while American Express is focusing on growth initiatives. Thermo Fisher’s shares have underperformed the Medical – Instruments industry, but the company is prioritizing customer partnerships. Steel Partners’ shares have outperformed the Diversified Operations industry, driven by strong customer demand. Oil-Dri’s shares have outperformed the Chemical – Diversified industry, despite rising costs. Other noteworthy reports include Broadcom, Deere, and Starbucks.



Read more at Zacks Investment Research: Top Research Reports for Eli Lilly, American Express & Thermo Fisher – April 10, 2025